Up a level |
Lawrence, David S, Youssouf, Nabila, Molloy, Sile LF, Alanio, Alexandre, Alufandika, Melanie, Boulware, David R, Boyer-Chammard, Timothee, Chen, Tao ORCID: 0000-0002-5489-6450, Dromer, Francoise, Hlupeni, Admire et al (show 19 more authors)
(2018)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
TRIALS, 19 (1).
649-.
Lawrence, David S, Youssouf, Nabila, Molloy, Sile F, Alanio, Alexandre, Alufandika, Melanie, Boulware, David R, Boyer-Chammard, Timothee, Chen, Tao ORCID: 0000-0002-5489-6450, Dromer, Francoise, Hlupeni, Admire et al (show 19 more authors)
(2019)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (vol 19, 649, 2018).
TRIALS, 20 (1).
48-.
Ponatshego, Ponego Lloyd, Lawrence, David Stephen, Youssouf, Nabila, Molloy, Sile F, Alufandika, Melanie, Bango, Funeka, Boulware, David R, Chawinga, Chimwemwe, Dziwani, Eltas, Gondwe, Ebbie et al (show 28 more authors)
(2019)
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
BMJ OPEN, 9 (4).
e026288-.
Lawrence, David S, Muthoga, Charles, Meya, David B, Tugume, Lillian, Williams, Darlisha, Rajasingham, Radha, Boulware, David R, Mwandumba, Henry C, Moyo, Melanie, Dziwani, Eltas N et al (show 25 more authors)
(2022)
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.
LANCET GLOBAL HEALTH, 10 (12).
E1845-E1854.